Instead, its your bodys way of adapting
Providers who stay informed about regulatory updates, insurance trends, and patient education needs will be better positioned to navigate this evolving treatment environment
Dosing frequency GLP-1s vary in their dosing frequency, which can significantly impact patient adherence and preference: Twice-daily: Exenatide (Byetta) Once-daily: Liraglutide (Victoza, Saxenda), Semaglutide tablets (Rybelsus) Once-weekly: Semaglutide (Ozempic, Wegovy), Dulaglutide (Trulicity), Exenatide extended-release (Bydureon), Tirzepatide (Mounjaro, Zepbound) The once-weekly formulations generally offer greater convenience and may improve adherence
Beyond death, inflammation has quantifiable negative effects on quality of life
Prioritising protein intake (at least 1.2-1.6g per kilogram of body weight) and regular strength training helps preserve muscle while losing fat
theoretical risks include increased hypoglycaemia, unpredictable cardiovascular effects, and compounded uncertainty from two incompletely characterised compounds